Video
Regular short-format conferences that provide all the key elements of a traditional conference! Learn more.
Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.
Watch our interview with Bernart Olle, CEO of Vedanta Biosciences.
We discussed the rationale of probiotics in urogenital female healthcare and after pregnancy with gynaecologist Franco Vicariotto.
We discussed the dermobiotic approach with Marco Pignatti (Dermatologist, University of Modena, Italy).
PharmaBiome has developed unique technologies to access the entire range of intestinal bacteria. We met Christophe Lacroix, Founder of Pharmabiome.
ProDigest recreates the gastrointestinal tract to assess the mechanism of action of components such as prebiotics, probiotics or drugs.
We discussed the role of the microbiome in HPV-positive head and neck cancer patients with Marc Oliva Bernal (Institut Català d’Oncologia, Spain).
Does the microbiota contribute to breast cancer development? We asked this question to Sridhar Mani, from the Albert Einstein College of Medicine in New York (USA).
Rémy Burcelin explains how understanding the link between gut microbiota, metabolic syndrome and cancer could be useful from a therapeutic point of view.
